DNSP-11
A compound studied to protect the brain cells lost in Parkinson's. An 11-amino-acid peptide from the proGDNF domain (the prodomain of glial cell line-derived neurotrophic factor, GDNF), also called Dopamine Neuron Stimulating Peptide-11. Pre-clinical neuroprotection for dopaminergic neurons in Parkinson's models.
DNSP-11: A compound studied to protect the brain cells lost in Parkinson's. An 11-amino-acid peptide from the proGDNF domain (the prodomain of glial cell line-derived neurotrophic factor, GDNF), also called Dopamine Neuron Stimulating Peptide-11. Pre-clinical neuroprotection for dopaminergic neurons in Parkinson's models. DNSP-11 is a tiny peptide derived from the precursor of dopamine.
DNSP-11 is a tiny peptide derived from the precursor of dopamine. It protects dopaminergic neurons in Parkinson's animal models. Pre-clinical research only, there is no human protocol, and dosing community vendors sell does not match clinical trial material.
Who it's for
- →Researchers studying Parkinson's disease pathways
- →Neurodegeneration research contexts
- →Educational reference, limited human data
What to expect
- Week 1
Subtle. No published human user-reports of acute effect.
- Week 4
Animal-model neuroprotection markers shift here.
- Week 8
No long term human data exists.
Looking at DNSP-11? Your next 3 steps
- 1Work out your exact dose
Vial size + BAC water turns into the exact units to draw for DNSP-11.
Open calculator → - 2See what to stack & monitor
The companion supplements and the bloodwork worth tracking on this kind of protocol.
Bloodwork guide → - 3Save it & ask the Coach
A free account saves your stack; membership adds the stack-aware AI Coach.
Create free account →
How it works (mechanism)
11-amino-acid peptide from the proGDNF domain (the prodomain of glial cell line-derived neurotrophic factor, GDNF). Pre-clinical neuroprotection via direct neurotrophic action on dopaminergic neurons.
Dosing protocol
Stacks well with
Side effects
When NOT to use
- ⚠Active psychiatric medication regimen affecting dopamine
- ⚠Pregnancy / nursing
- ⚠Anyone risk-averse to pre-clinical compounds
Common mistakes
- • Treating it as Parkinson's treatment (it's pre-clinical research)
- • Stacking it with dopamine agonists
- • Long cycles without safety data
New to DNSP-11? Grab the starter checklist.
Drop your email and we'll send the one-page first-cycle starter checklist, plus a heads-up if DNSP-11 changes legal status. No account needed.
No spam. No selling your email. Just the checklist and the occasional reclassification alert.
Ask the Coach anything about DNSP-11 or your own stack. This is it working.
Trained only on Pepdex content. Does the dose math, flags interactions, knows your stack. Won't push vendors, won't pretend to be a doctor.
Get the Coach, $7.99/mo →Frequently asked
What is DNSP-11?+
Is DNSP-11 FDA approved?+
Is DNSP-11 legal?+
Is DNSP-11 banned by WADA?+
Are you still natty after taking DNSP-11?+
Do doctors prescribe DNSP-11?+
What's the typical dose of DNSP-11?+
What are the side effects of DNSP-11?+
How long until DNSP-11 starts working?+
What can you stack with DNSP-11?+
Where do people get DNSP-11?+
More in Nootropic
The 'bonding hormone' you make naturally. Synthetic oxytocin is FDA-approved for labor; off-label use covers social, anxiety, and intimacy contexts.
A brain-recovery drug used abroad for stroke, head injury, and Alzheimer's. A porcine brain-derived peptide complex used clinically in 50+ countries (Russia, China, Mexico, EU) for stroke recovery, TBI, and Alzheimer's. It's a mixture of low-molecular-weight peptides, not a single compound.
For alertness and focus. A Russian-origin nootropic peptide on the alert/focus end of the spectrum that pairs with Selank for a balanced cognitive stack.
A brain compound aimed at building new connections between neurons. An angiotensin IV analog with strong synaptogenic effect in animal models, often-cited as 'BDNF on steroids.' Very limited human data.